The current pilot data, along with the weight loss findings from the main phase two trial, further support the use of retatrutide in people with NASH. Julio Rosenstock, MD, Principal Investigator and Director of Velocity Clinical Research at Medical City and Clinical Professor of Medicine at the University of Texas (UT) Southwestern, discussed the efficacy and safety results from the Retatrutide for People with Type 2 Diabetes Phase 2 Study
Initiate Your Tirzepatide Journey with Klinic in Hartford Starting your tirzepatide treatment through Klinic involves simple steps, all aimed at maximizing your convenience and health outcomes
While L-Carnitine Tartrate is commonly used as a sports supplement, acetyl L-Carnitine is more commonly used alongside medical treatments
Limit Refined Carbohydrates and Sugars Highly processed carbs and sugary foods may blunt GLP-1 response and contribute to insulin resistance
Kim JK, Gimeno RE, Higashimori T, Kim HJ, Choi H, Punreddy S, et al
Abstract Background and Objectives: The gut hormones peptide YY (PYY) and glucagon-like peptide 1 (GLP-1) acutely suppress appetite